VEGFR (Vascular Endothelial Growth Factor Receptor) Inhibition Induces Cardiovascular Damage via Redox-Sensitive Processes.

Hypertension
Karla B NevesRhian M Touyz

Abstract

Although VEGF (vascular endothelial growth factor) inhibitors (VEGFIs), are effective anticancer therapies, they cause hypertension through unknown mechanisms. We questioned whether changes in vascular redox state may be important, because VEGF signaling involves nitric oxide (NO) and reactive oxygen species. Molecular mechanisms, including NOS, NADPH oxidase (Nox)-derived reactive oxygen species, antioxidant systems, and vasoconstrictor signaling pathways, were probed in human endothelial cells and vascular smooth muscle exposed to vatalanib, a VEGFI. Vascular functional effects of VEGFI were assessed ex vivo in mouse arteries. Cardiovascular and renal in vivo effects were studied in vatalanib- or gefitinib (EGFI [epidermal growth factor inhibitor])-treated mice. In endothelial cells, vatalanib decreased eNOS (Ser1177) phosphorylation and reduced NO and H2O2 production, responses associated with increased Nox-derived O2- and ONOO- formation. Inhibition of Nox1/4 (GKT137831) or Nox1 (NoxA1ds), prevented vatalanib-induced effects. Nrf-2 (nuclear factor erythroid 2-related factor 2) nuclear translocation and expression of Nrf-2-regulated antioxidant enzymes were variably downregulated by vatalanib. In human vascular smooth muscle...Continue Reading

References

Dec 4, 2003·Biochemical Society Transactions·I Zachary
Feb 12, 2008·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Indika EdirisingheIrfan Rahman
Mar 7, 2008·Antioxidants & Redox Signaling·Eberhard SchulzThomas Münzel
Sep 24, 2009·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Michael L MaitlandMark J Ratain
Oct 12, 2010·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Hyung Wook KimCheol Whee Park
Jun 10, 2011·American Journal of Physiology. Cell Physiology·Youxue WangFiemu E Nwariaku
Mar 1, 2012·Cell Stress & Chaperones·Mohammad MohammadzadehMehryar Habibi Roudkenar
Mar 30, 2012·Circulation Research·Katrin SchröderRalf P Brandes
Jun 19, 2012·Journal of the American College of Cardiology·J Todd BelcikJonathan R Lindner
Aug 10, 2012·Physiology·Michael Simons
Nov 7, 2012·Cell Biochemistry and Function·Claire E Clarkin, Louis C Gerstenfeld
Apr 23, 2013·Antioxidants & Redox Signaling·Augusto C Montezano, Rhian M Touyz
Aug 1, 2013·World Journal of Gastroenterology : WJG·Camila MarquesNorma Possa Marroni
Sep 14, 2014·Critical Reviews in Oncology/hematology·Simon Abi AadElie Mouhayar
Oct 30, 2015·Current Pharmaceutical Design·Elsa C ChanGregory J Dusting
Jul 28, 2016·Nature Reviews. Molecular Cell Biology·Michael SimonsLena Claesson-Welsh
Aug 6, 2016·Frontiers in Physiology·Raj Sewduth, Massimo M Santoro
Sep 11, 2016·Clinical Science·Srila GopalIris Z Jaffe
Oct 13, 2016·The New England Journal of Medicine·Javid J Moslehi
Dec 18, 2016·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Joanne J CarterJeanette Woolard
Apr 19, 2017·Experimental Eye Research·Monique MatsudaNádia Campos de Oliveira Miguel

❮ Previous
Next ❯

Citations

Jul 13, 2019·Cardiovascular Research·Kristen J BubbGemma A Figtree
Feb 6, 2020·Experimental and Therapeutic Medicine·Zengtao WangJie Zhang
Aug 20, 2019·Archives of Pharmacal Research·Diem Thi Ngoc Huynh, Kyung-Sun Heo
Sep 30, 2020·Clinical Science·Karla B NevesRhian M Touyz
Mar 24, 2020·Clinical Science·Paula K Bautista-NiñoAnton J M Roks
Jul 1, 2018·Current Hypertension Reports·Stefano CalettiDamiano Rizzoni
Dec 13, 2019·Antioxidants & Redox Signaling·Mathieu Chocry, Ludovic Leloup
Feb 7, 2019·Cardiovascular Research·Jorie VersmissenA H Jan Danser
Jan 7, 2021·Clinical Science·Stephen J H DobbinNinian N Lang
Nov 29, 2020·Free Radical Biology & Medicine·Tiago J CostaFrancesc Jiménez-Altayó
Feb 24, 2021·British Journal of Clinical Pharmacology·Pietro AmeriItalo Porto
Apr 2, 2021·Circulation Research·Daan C H van DorstNinian N Lang
Aug 14, 2021·Frontiers in Cardiovascular Medicine·Po-Yen HsuCanan G Nebigil
Sep 1, 2021·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Qing LiuTianshu Liu
Oct 23, 2020·Ceská a slovenská oftalmologie : casopis Ceské oftalmologické spolecnosti a Slovenské oftalmologické spolecnosti·J Slíva

❮ Previous
Next ❯

Related Concepts

Related Feeds

Arterial-Venous in Development & Disease

Arterial-venous development may play a crucial role in cardiovascular diseases. Here is the latest research.

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.